VMBIP Newsletter – May 2, 2008

Please scroll past the charts for VMBIP updates.

McKesson Performance Dashboard 
CDC Weekly Performance Metric Scorecard

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending April 11, 2008: 81 percent
Week Ending April 18, 2008: 84.9 percent
Week Ending April 25, 2008: 94.5 percent
Weighted Average Last 3 Weeks: 86.3 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending April 11, 2008: 100 percent
Week Ending April 18, 2008: 99.8 percent
Week Ending April 25, 2008: 98.4 percent
Weighted Average Last 3 Weeks:  99.5 percent
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending April 11, 2008: 100 percent
Week Ending April 18, 2008: 99.88 percent
Week Ending April 25, 2008: 99.90 percent
Weighted Average Last 3 Weeks:  99.92 percent
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending April 11, 2008: 99.99 percent
Week Ending April 18, 2008: 99.50 percent
Week Ending April 25, 2008: 98.59 percent
Weighted Average Last 3 Weeks:  99.40 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending April 11, 2008: 100 percent
Week Ending April 18, 2008: 99.96 percent
Week Ending April 25, 2008: 99.97 percent
Weighted Average Last 3 Weeks:  99.98 percent
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending April 11, 2008: 100 percent
Week Ending April 18, 2008: 100 percent
Week Ending April 25, 2008: 100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  none

F
Metric: State Funded PO Transmission
Week Ending April 11, 2008: 100 percent
Week Ending April 18, 2008: 100 percent
Week Ending April 25, 2008: 95 percent
Weighted Average Last 3 Weeks:  98 percent
Explanation:  4/25: One PO exception occurred due to difficulty in getting the PO scanned.  The exception was flagged by the report and corrected immediately.  Four receiving were excluded because they were federal but received as non-federal

A.  Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		 
B.  Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder	
C1.  Percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship,  undeliverable/customer not available, or carrier damageC2.  Percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect      address/delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.   Percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.   Percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and  transmits to CDC within 24 (flu) / 48 (other) hrs of delivery by manufacturer	
F.   Percent of grantee replenishment orders McKesson faxes/e-mails receipt of to grantees within 48 hrs of delivery by manufacturer Vaccines placed on backorder during the most recent week: DTAP-HIB (40 doses) – Delayed arrival of the replenishment order from manufacturers caused a temporary (two day) stock-out; Hep AB (730 doses) – Delayed arrival of the replenishment order from manufacturers caused a temporary (one day) stock-out 

McKesson Performance Dashboard – Shipping Metrics by Distribution Center
CDC Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending April 18, 2008: 82 percent
Week Ending April 25, 2008: 94.2 percent
Weighted Average Last 2 Weeks: 87.3 
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending April 18, 2008: 99.9 percent
Week Ending April 25, 2008: 99.6 percent
Weighted Average Last 2 Weeks:   99.7 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending April 18, 2008: 91.4 percent
Week Ending April 25, 2008: 95.2 percent
Weighted Average Last 2 Weeks:  93 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending April 18, 2008: 99.8 percent
Week Ending April 25, 2008: 95.4 percent
Weighted Average Last 2 Weeks: 98 percent
Explanation:  none

A.  Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		 
B.  Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder	
C1.  Percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable/customer not available, or carrier damageC2.  Percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect      address/delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.   Percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.   Percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and  transmits to CDC within 24 (flu) / 48 (other) hrs of delivery by manufacturer	
F.   Percent of grantee replenishment orders McKesson faxes/e-mails receipt of to grantees within 48 hrs of delivery by manufacturer
 
VMBIP Updates
•	As you may know, DT, HBIG, and all other vaccines/biologicals that do not exist on the federal contract are stored as grantee-specific inventory at the McKesson warehouses. When you purchase these vaccines with state and/or 317 FA funds to be shipped to McKesson Specialty Distribution, these products are physically segregated in grantee-specific bins as "virtual inventory." Occasionally grantees place unusually large bulk orders of DT. In addition, one grantee has seven doses of HBIG still in inventory at the Memphis warehouse that will expire 9/16/08. We are concerned that these situations may result in some doses expiring before they can be administered. We are in the process of establishing a process for you to be able to transfer doses from your virtual inventory into another transitioned grantee's virtual inventory. We will send out an all-grantee message detailing the process once it is finalized.
•	We are in the process of establishing an after-hours/weekend vaccine ordering process for grantees who need to request a rush vaccine shipment in response to a public health emergency. We will send out an all-grantee message detailing the process once it is finalized.
•	You recently received an all-grantee message asking you to respond to an open-ended question soliciting your current top three process areas of concern about centralized distribution. Please be sure to list current, unresolved issues and to respond before the deadline of May 13. We plan to share summary findings during the centralized distribution plenary at the Vaccine University.

As a reminder, VMBIP related all grantee messages are posted to the VMBIP website at: http://www.cdc.gov/vaccines/programs/vmbip/documents.htm  and previous newsletters are posted at http://www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

A Word version of this newsletter is attached. If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov   or Julie Orta jio7@cdc.gov , with a cc to your project officer.

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8215 (main)
404-639-8615 (fax)
bap3@cdc.gov 

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-05-02-08.rtf